Last week, our team paused the day-to-day work for our annual deep-dive into new technologies and scientific insights to help shape our roadmap for the coming year. It encourages us to stay curious, to push ourselves and our boundaries, and to keep innovating.

This edition focused on two core areas:
🧬 further strengthening our ImmunoEngine, our data-driven antigen discovery platform, and
🧠 deepening our understanding of tumor biology and the origin of metastasis.

Jens De Ceukerleire, Manon Montyne, Lena Pfitzer, Emiel Evenepoel, Gitta Boons and Marie Van Hecke presented their insights to the whole group which sparked inspiring discussions and novel ideas.

The perspectives gained during this Thematic Week will directly inform our 2026 development roadmap and strengthen our pursuit of innovative solutions for patients with unmet medical needs.